From the Journals

Daptomycin safe, effective for pediatric cSSSI treatment

Publish date: February 15, 2017
By
Lucas Franki

 

FROM PEDIATRICS

Daptomycin was safe and effective at treating complicated skin and skin structure infections (cSSSI) in children aged 1-17 years, according to Dr. John Bradley of the University of California, San Diego, and his associates.

A total of 389 cSSSI patients were included in the study, with 257 receiving daptomycin and 132 receiving standard-of-care (SOC) treatment (mostly vancomycin or clindamycin). Clinical success rates were similar for both groups, at 91% in the daptomycin group and 87% in the SOC group. Therapeutic success rates also were similar, at 97% in the daptomycin group and 99% in the SOC group.

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria Courtesy U.S. National Institute of Allergy and Infectious Diseases

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria

Adverse event incidence was similar in both groups, occurring in 14% of daptomycin patients and in 17% of SOC patients. The most common adverse events were diarrhea, occurring in 7% of daptomycin patients and 5% of SOC patients, and increased creatine phosphokinase, occurring in 6% of daptomycin patients and 5% of SOC patients.

“Daptomycin is a suitable once-daily alternative to vancomycin or clindamycin in the pediatric setting, particularly for suspected or confirmed MRSA [methicillin-resistant Staphylococcus aureus] infections,” the investigators concluded.

Find the full study in Pediatrics (doi: 10.1542/peds.2016-2477).

Recommended Reading

New Zika-infected pregnancies down for most of United States
MDedge Pediatrics
A-T Children’s Project Publishes Handbook on Caring for People With Ataxia-Telangiectasia
MDedge Pediatrics
High levels of flu activity reported in 15 states
MDedge Pediatrics
Teen vaccines: Where we are now, and how can we go further?
MDedge Pediatrics
Adverse event reporting in second-dose varicella vaccination shows no surprises
MDedge Pediatrics
Crusted scabies outbreak: How much prophylaxis?
MDedge Pediatrics
Antibiotics have a role in PANS even with no infection
MDedge Pediatrics
The last call
MDedge Pediatrics
Bronchiolitis pathway adherence tied to shorter LOS, lower costs
MDedge Pediatrics
Flu activity levels high in 23 states
MDedge Pediatrics